Your browser doesn't support javascript.
loading
Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.
Katagiri, S; Akahane, D; Amano, K; Ohyashiki, K.
Affiliation
  • Katagiri S; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Akahane D; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Amano K; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
  • Ohyashiki K; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
Haemophilia ; 22(6): e557-e559, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27641423
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Bortezomib / Anti-Inflammatory Agents / Multiple Myeloma / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Bortezomib / Anti-Inflammatory Agents / Multiple Myeloma / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom